Normal Tilt Table, Still Sick? What the 2026 International POTS Consensus Says About the Patients the Criteria Miss
You stood for ten minutes. Your heart rate went up 24 beats. The cardiologist said your test was normal, that POTS was ruled out, and that you should drink more water and try to reduce your stress. You went home still dizzy, still exhausted, still unable to stand in a grocery store line without your vision graying out — and now without even a name for it.
If that is your story, a consensus document published in The American Journal of Medicine in August 2026 is the most useful thing you will read this year. It does not announce a new treatment. It says something more basic, and more validating: the diagnostic threshold itself is leaving people behind.
What the 2026 international consensus actually says
An international panel of 40 contributors from seven countries — pediatric and adult specialists in POTS and dysautonomia, plus patient advocacy representatives — used a modified Delphi process to vote on 31 consensus statements covering recognition, diagnosis, treatment, functional impact, and research priorities. Agreement was set in advance at 70 percent. Every one of the 31 statements cleared 90 percent, and 24 of the 31 were unanimous.
The central problem the panel set out to address is stated plainly in the paper itself. Current criteria require a history of orthostatic intolerance plus a heart rate rise of at least 30 beats per minute in adults, or at least 40 in adolescents, during a 10-minute stand or tilt table test. In the authors’ words, many patients with orthostatic intolerance experience autonomic dysfunction and functional impairment despite not meeting the required heart rate increase — and those patients remain undiagnosed, untreated, and excluded from research studies.
Why “you don’t meet criteria” is not the same as “nothing is wrong”
A diagnostic threshold is a line drawn to make research comparable. It is not a measurement of how sick someone is. A number was chosen, and people whose physiology lands just underneath it fall off the map — out of the diagnosis, out of the treatment pathway, and out of the studies that would eventually have described them.
The consensus panel gave that group a name it did not have before: non-POTS dysautonomia. Naming it matters, because it is what makes a patient legible to the system. It is also why so many people in this situation have been told, sincerely and incorrectly, that their problem must be anxiety.
Why the numbers you find online are all over the map
Search for how often POTS and hypermobility occur together and you will find figures that seem to contradict each other outright. They are not errors — they are the same phenomenon measured in different populations, and the spread is itself the finding.
Ehlers-Danlos and POTS
A systematic review published in Autonomic Neuroscience in June 2026 pooled 30 studies covering 8,421 patients with Ehlers-Danlos syndrome and 12,983 patients with POTS. Across 16 studies reporting it, the average age was 33.3 years. The prevalence of POTS among EDS patients ranged from 17.5 percent to 92.7 percent depending on the population studied. EDS among POTS patients ranged from 17.9 percent to 50.0 percent. The authors’ conclusion is deliberately careful: the two conditions frequently co-occur, and the proportions depend entirely on who you are counting.
The gut connection almost nobody connects
A meta-analysis in Alimentary Pharmacology & Therapeutics in July 2026 pooled 19 studies covering 17,455 patients with hypermobile EDS or hypermobility spectrum disorder against more than 1.6 million controls. The odds of chronic gastrointestinal symptoms were roughly four times higher than in controls (OR 4.29, 95% CI 3.1–6.0), and 65.3 percent reported at least one chronic GI symptom. Among non-gut comorbidities, chronic fatigue was the most common at 49 percent, followed by migraine at 38.2 percent and orthostatic intolerance at 35.9 percent.
Look at the POTS figure in that same analysis and you can watch the measurement problem happen in real time: 21.9 percent, with a 95% confidence interval running from 5.2 to 59.1 percent. That is not a number anyone should quote as a fact. The authors say so themselves, rating the overall quality of evidence as low because of clinical heterogeneity, and cautioning that association is not causation. The picture is real. What it means is not settled.
What this research does not say
It does not say that everyone who feels dizzy standing up has dysautonomia. It does not say the heart rate criterion is worthless — it remains the standard, and the consensus panel did not discard it. It does not identify a treatment that resolves POTS or non-POTS dysautonomia, and it does not evaluate any infusion, injection, or supplement.
What it does establish is that a negative tilt table result rules out a diagnosis, not a problem — and that a patient in that position deserves a real evaluation rather than a dismissal.
What to ask a provider
If you have been told you do not meet criteria, these questions move the conversation forward:
- What was my actual heart rate change, supine to standing, and over what interval was it measured?
- Was I well hydrated, and had I held medications that raise or blunt heart rate?
- Have the treatable conditions that mimic this been ruled out — anemia, thyroid disease, adrenal insufficiency, structural cardiac disease?
- Given the 2026 international consensus statement on POTS and non-POTS dysautonomia, does my presentation fit what it describes?
- What non-drug measures are worth trying first?
Who is generally not a good candidate for integrative dysautonomia care
Being honest about this matters more than any testimonial. An integrative program is generally not the right starting point if:
- You have not had a basic cardiac and medical workup. Orthostatic symptoms can come from arrhythmia, structural heart disease, anemia, or thyroid dysfunction. Those need to be excluded first, by the appropriate specialist.
- You are looking for a single infusion to resolve this. No single infusion resolves POTS or dysautonomia, and we will not suggest otherwise.
- You want to stop cardiology or neurology care and substitute this for it. Venturis Clinic is not a cardiology or neurology practice. Integrative care is intended to work alongside those specialists, not replace them.
- Your symptoms are acute or rapidly worsening — chest pain, syncope with injury, new neurological deficits. That is an urgent evaluation, not an outpatient wellness consultation.
- You are unable or unwilling to address the foundational measures — fluids, sodium as directed by your physician, compression, and graded recumbent exercise. These are the backbone of care, and nothing layered on top substitutes for them.
Where an Oklahoma City integrative clinic fits
Venturis Clinic works with complex chronic illness — the patients who arrive with a folder of normal labs and no explanation. Our POTS integrative treatment approach begins with a long evaluation rather than a protocol, because the overlaps described above are common and are frequently missed. We have written separately about why MCAS, POTS, and EDS travel together and about what MCAS diagnostic criteria actually involve.
To be explicit about regulatory status: several therapies used in integrative programs, including ozone and intravenous nutrient therapies, are not FDA-approved for the treatment of POTS or dysautonomia. Candidates are evaluated individually during a consultation, and results vary.
Frequently asked questions
Can you have POTS with a normal tilt table test?
By current criteria, a formal POTS diagnosis requires the heart rate rise of at least 30 bpm in adults or 40 bpm in adolescents. The 2026 international consensus statement addresses patients who have orthostatic intolerance and autonomic dysfunction without reaching that threshold, and refers to this group as non-POTS dysautonomia. A normal test does not mean nothing is wrong; it means this particular diagnostic label does not apply.
What heart rate increase is needed to diagnose POTS?
At least 30 beats per minute in adults and at least 40 beats per minute in adolescents, sustained during a 10-minute standing test or tilt table test, together with a history of orthostatic intolerance.
What is non-POTS dysautonomia?
It is the term used in the 2026 international multidisciplinary consensus for patients who have autonomic dysfunction and real functional impairment but whose heart rate response does not meet the POTS threshold. The panel highlighted that these patients have historically been left undiagnosed, untreated, and excluded from research.
Do Ehlers-Danlos syndrome and POTS occur together?
Frequently, though the reported rates vary widely by population. A 2026 systematic review found POTS in 17.5 to 92.7 percent of EDS patients and EDS in 17.9 to 50.0 percent of POTS patients across 30 studies. The breadth of that range is why no single percentage should be treated as the answer.
Why do I have stomach problems along with dizziness?
Gastrointestinal symptoms are strongly associated with hypermobile EDS and hypermobility spectrum disorders. A 2026 meta-analysis found roughly four-fold higher odds of chronic GI symptoms compared with controls, with 65.3 percent of patients reporting at least one. These should be evaluated together rather than referred out separately.
Do compression garments help POTS?
A randomized study in The Canadian Journal of Cardiology tested commercially available abdominal-only compression garments across four 10-minute stand tests in one day. With the garment on, median standing heart rate was 103 bpm versus 118 without it, and the rise from supine to standing was 27 beats versus 41. Symptom scores improved, and both heart rate and symptoms went back up when the garment was removed after several hours. The authors describe abdominal compression as a possible alternative to full waist-high garments. Discuss it with your provider before relying on it.
Is POTS the same thing as anxiety?
No. They can produce overlapping sensations — racing heart, shakiness, difficulty concentrating — and misattribution is common, particularly in patients whose testing falls short of formal criteria. Orthostatic intolerance is a measurable physiologic response to upright posture, and a careful evaluation can distinguish the two.
Where can I get evaluated for dysautonomia in Oklahoma City?
Venturis Clinic sees patients from Oklahoma City, Edmond, Norman, Moore, Yukon, Mustang, Bethany, and the surrounding metro. You can request an appointment or book a free 15-minute phone consultation to discuss whether an integrative evaluation makes sense for your situation.
Talk with us
If you have been told your test was normal and you are still not functioning, a longer conversation is a reasonable next step.
Venturis Clinic
7917 N May Ave, Suite B
Oklahoma City, OK 73120
(405) 848-7246
This content is for educational purposes only and is not medical advice, diagnosis, or treatment. Individual results vary and no outcome is guaranteed. Venturis Clinic offers regenerative, functional, and alternative medicine services; some therapies discussed are not FDA-approved for the uses described. Talk with a qualified healthcare provider about your specific situation before beginning any treatment.
Sources
- Sivakoti K, Cortez M, Fedorowski A, et al. Postural Orthostatic Tachycardia Syndrome (POTS) and Dysautonomia: International Multidisciplinary Expert Consensus. The American Journal of Medicine. 2026. DOI: 10.1016/j.amjmed.2026.08.012
- Kwok CS, Hagger G, Gillespie D, et al. The co-existence of Ehlers-Danlos syndrome and postural orthostatic tachycardia syndrome: A systematic review of the literature. Autonomic Neuroscience. 2026;267:103453. DOI: 10.1016/j.autneu.2026.103453
- Kulin D, Holtmann G, Fairlie T, et al. Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders. Alimentary Pharmacology & Therapeutics. 2026;64(5):574–589. DOI: 10.1111/apt.70856
- Bourne KM, Karalasingham K, Siddiqui T, et al. Abdominal-only Compression Garments Reduce Orthostatic Tachycardia and Improve Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome. The Canadian Journal of Cardiology. 2026;42(6):1320–1328. DOI: 10.1016/j.cjca.2025.11.038
